About Canntab: Canntab Therapeutics is a Canadian biopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. Long referred to as Cannabis 3.0 by the Company, Canntab’s proprietary hard pill cannabinoid formulations provide doctors, patients and consumers with medical grade solutions which incorporate all the features one would expect from any prescription or over the counter medication sold in pharmacies around the world. These will include the following formulations: once a day and extended release, both providing an accurate dose and improved shelf stability. Canntab holds a Cannabis Standard Processing & Sales for Medical Purposes License, a Cannabis Research License, and an Industrial Hemp License from Health Canada. Canntab trades on the Canadian Securities Exchange under the symbol PILL, on the OTCQB under the symbol CTABF, and on the Frankfurt Stock Exchange under the symbol TBF1. About Equity Guru: Investment information for millennials and madmen. Expert analysis, no punches pulled and no investors left behind. Want to get involved in the public markets, but feel ill-equipped? Already in the markets, but looking for honest source of insight? We can provide the resources that keep you informed, help you build the necessary tools or assist in honing your existing skillset so you can make your investment goals achievable today. Small cap, mid cap, large cap, we cover them all. No the matter the exchange be it, TSX-V, CSE, OTC, NYSE and/or NASDAQ, we have our finger on the pulse. Whether you are a day trader or value investor, we have your back.

Disclaimer: http://bit.ly/EGdisclaimer